Seeing Is Believing
BBI is currently covered by 2 analysts with an average price target of $0.53. This is a potential upside of $-0.37 (-41.11%) from yesterday's end of day stock price of $0.9.
Brickell Biotech's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of BBI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 9.67 days.
Highest price target for BBI is $8, Lowest price target is $3, average price target is $0.53.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HCWAINWRIGHT on 16-Aug-2022. First documented stock forecast 18-Jan-2022.
Currently out of the existing stock ratings of BBI, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4.5
$3.53 (363.92%)
1 years 8 months 7 days ago
0/1 (0%)
$1.04 (30.06%)
Buy
11.25
$10.35 (1150.00%)
1 years 11 months 10 days ago
0/1 (0%)
$2.87 (34.25%)
Buy
35
2 years 1 months 7 days ago
1/1 (100%)
$-5.01 (-12.52%)
29
What is BBI (Brickell Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on BBI (Brickell Biotech) with a proven track record?
Which analyst has the current lower performing score on BBI (Brickell Biotech) with a proven track record?
Which analyst has the most public recommendations on BBI (Brickell Biotech)?
Which analyst is the currently most bullish on BBI (Brickell Biotech)?
Which analyst is the currently most reserved on BBI (Brickell Biotech)?